

Enable broad access to breast cancer drug Kadcyla
The Issue
Like many of us with experience of HER2+ breast cancer, I'm dismayed by the NICE decision to withdraw funding for Kadcyla, also known as TDM-1. News reports highlight that this drug can give an extra 6 months of life in women with advanced breast cancer. However, I find this statement frustrating, especially as data on this drug is still being gathered. NICE consider Kadcyla to be something which is used at the end of life, when initial findings suggest that it is capable of providing additional years of quality life, sometimes resulting in women becoming NED ( no evidence of disease) for the first time.
I feel this is another example of perceptions not catching up with research. Those of us with advanced breast cancer are perceived to be at the end of our lives, when we are capable of work, caring for family and achieving things which many people considered to be much fitter could not accomplish.
Thanks to research, breast cancer is no longer an automatic death sentence. It might not be curable in some cases, but as I have found out, it is definitely treatable and manageable. If our condition were perceived less as "The Big C" and more like other serious chronic conditions, such as Parkinson's, heart disease or MS, drugs might be considered better value, aimed at preventing costly hospital admissions and dependence on sickness benefits. Most of all, there would be an assumption of survival, rather than an attitude of giving treatment as a last resort.
I have, and continue to benefit from the Cancer Drugs Fund. Having ongoing Herceptin and Pertuzumab will give me the best possible chance of keeping my cancer at bay for many years to come. However, this fund will close in 2016, and it makes me sad to think that other women will not be as fortunate as me.
We are so close to an effective treatment, and possibly a cure for several types of breast cancer. Research is being financed from charity donations. It seems wrong that the drugs resulting from that research are priced out of our reach.

Petition Closed
The Issue
Like many of us with experience of HER2+ breast cancer, I'm dismayed by the NICE decision to withdraw funding for Kadcyla, also known as TDM-1. News reports highlight that this drug can give an extra 6 months of life in women with advanced breast cancer. However, I find this statement frustrating, especially as data on this drug is still being gathered. NICE consider Kadcyla to be something which is used at the end of life, when initial findings suggest that it is capable of providing additional years of quality life, sometimes resulting in women becoming NED ( no evidence of disease) for the first time.
I feel this is another example of perceptions not catching up with research. Those of us with advanced breast cancer are perceived to be at the end of our lives, when we are capable of work, caring for family and achieving things which many people considered to be much fitter could not accomplish.
Thanks to research, breast cancer is no longer an automatic death sentence. It might not be curable in some cases, but as I have found out, it is definitely treatable and manageable. If our condition were perceived less as "The Big C" and more like other serious chronic conditions, such as Parkinson's, heart disease or MS, drugs might be considered better value, aimed at preventing costly hospital admissions and dependence on sickness benefits. Most of all, there would be an assumption of survival, rather than an attitude of giving treatment as a last resort.
I have, and continue to benefit from the Cancer Drugs Fund. Having ongoing Herceptin and Pertuzumab will give me the best possible chance of keeping my cancer at bay for many years to come. However, this fund will close in 2016, and it makes me sad to think that other women will not be as fortunate as me.
We are so close to an effective treatment, and possibly a cure for several types of breast cancer. Research is being financed from charity donations. It seems wrong that the drugs resulting from that research are priced out of our reach.

The Decision Makers
Petition Updates
Share this petition
Petition created on 9 August 2014